Data / Research funding / Arizona / Mayo Clinic Arizona
Mayo Clinic Arizona: 81 NIH awards ($108.9M), fiscal years 2021 to 2026
Mayo Clinic Arizona in Scottsdale, AZ is funded under 81 NIH awards ($108.9M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- ULMJJBL7ZXX3
- State
- Arizona
Awards
81 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Mayo Clinic Multiple Myeloma SPORE | NIH | National Cancer Institute | 2021 to 2025 | $10,422,043 | September 1, 2015 | August 31, 2026 | BERGSAGEL, PETER LEIF | reporter.nih.gov |
| Mathematical Oncology Systems Analysis Imaging Center (MOSAIC) | NIH | National Cancer Institute | 2023 to 2024 | $4,162,711 | September 18, 2023 | August 31, 2028 | SWANSON, KRISTIN R | reporter.nih.gov |
| Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma | NIH | National Cancer Institute | 2021 to 2022 | $4,031,557 | September 19, 2018 | June 30, 2024 | RIMSZA, LISA | reporter.nih.gov |
| Image-based models of tumor-immune dynamics in glioblastoma | NIH | National Cancer Institute | 2021 to 2025 | $3,775,245 | March 1, 2021 | February 28, 2027 | HU, LELAND | reporter.nih.gov |
| Drug eluting injectable biomaterials for next generation chemoembolization | NIH | National Cancer Institute | 2021 to 2025 | $3,173,416 | May 1, 2021 | April 30, 2027 | OKLU, RAHMI | reporter.nih.gov |
| Allergen-induced extracellular DNA in type 2 immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,163,994 | September 21, 2022 | July 31, 2027 | KITA, HIROHITO | reporter.nih.gov |
| Optimizing a patient-specific regenerative larynx implant for restoration of voice | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,070,095 | September 1, 2021 | August 31, 2027 | LOTT, DAVID G | reporter.nih.gov |
| Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen | NIH | National Cancer Institute | 2021 to 2025 | $3,068,738 | September 13, 2021 | August 31, 2027 | KHAZAIE, KHASHAYARSHA | reporter.nih.gov |
| Mechanisms of IL-33 secretion in allergic diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,942,746 | December 16, 2016 | January 31, 2027 | KITA, HIROHITO | reporter.nih.gov |
| Mechanisms of Allergen-induced Type 2 Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,733,347 | November 1, 2019 | April 30, 2028 | KITA, HIROHITO | reporter.nih.gov |
| Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,675,195 | August 9, 2022 | June 30, 2027 | ZHU, WUQIANG | reporter.nih.gov |
| Biomaterials for embolization and ablation of arterio-venous malformations | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,585,948 | July 1, 2022 | June 30, 2027 | OKLU, RAHMI | reporter.nih.gov |
| Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,301,317 | July 5, 2017 | November 30, 2026 | MILLER, LAURENCE J | reporter.nih.gov |
| Healing enterocutaneous fistulas using bioengineered biomaterials | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,223,844 | December 1, 2021 | November 30, 2026 | OKLU, RAHMI | reporter.nih.gov |
| Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,196,794 | January 1, 2023 | November 30, 2026 | ZHU, WUQIANG | reporter.nih.gov |
| Biomarker Signature to Predict the Persistence of Post-Traumatic Headache | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $2,111,462 | September 1, 2019 | July 31, 2025 | CHONG, CATHERINE DANIELA | reporter.nih.gov |
| How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,948,254 | July 1, 2022 | June 30, 2025 | GOUNARI, FOTINI | reporter.nih.gov |
| Fat in Pancreatitis - a Focus on Hypertriglyceridemic Pancreatitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,924,059 | July 6, 2011 | December 31, 2024 | SINGH, VIJAY PREM | reporter.nih.gov |
| Flexible NLP toolkit for automatic curation of outcomes for breast cancer patients | NIH | National Cancer Institute | 2022 to 2025 | $1,905,455 | August 1, 2022 | July 31, 2027 | BANERJEE, IMON | reporter.nih.gov |
| Control of antiviral memory CD8+ T cell longevity by extracellular ATP sensing | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,894,856 | July 1, 2022 | June 30, 2027 | BORGES DA SILVA, HENRIQUE | reporter.nih.gov |
| Impact of membrane composition on cholecystokinin receptor structure and function | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,863,035 | January 1, 2022 | November 30, 2026 | MILLER, LAURENCE J | reporter.nih.gov |
| preclinical optimization of BCMA directed T cell therapy | NIH | National Cancer Institute | 2023 to 2025 | $1,834,540 | September 20, 2023 | August 31, 2028 | CHESI, MARTA | reporter.nih.gov |
| The role of lymph node structural organization in naïve T cell decline with age | NIH | National Institute on Aging | 2023 to 2025 | $1,828,813 | August 1, 2023 | April 30, 2028 | LANCASTER, JESSICA N | reporter.nih.gov |
| STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22 | NIH | National Cancer Institute | 2023 to 2025 | $1,791,038 | February 21, 2023 | January 31, 2028 | TRAN, NHAN L | reporter.nih.gov |
| Role of SIRT7 in the Pancreatic Beta Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,639,907 | April 1, 2022 | March 31, 2027 | WEI, ZONG | reporter.nih.gov |
| Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training | NIH | National Cancer Institute | 2022 to 2025 | $1,471,316 | August 22, 2023 | July 31, 2027 | EHLERS, DIANE KRISTEN | reporter.nih.gov |
| Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,412,018 | December 2, 2021 | December 31, 2025 | ORTEGA, VICTOR E. | reporter.nih.gov |
| Targeting PP4 to improve ovarian cancer response to immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $1,403,025 | August 3, 2023 | July 31, 2028 | CURTIS, MARION | reporter.nih.gov |
| Opportunistic Screening for ASCVD using a Multimodal Deep Learning Risk Prediction Model | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,382,292 | December 15, 2023 | November 30, 2028 | BANERJEE, IMON | reporter.nih.gov |
| Electrically Conductive Stem Cell Derived MicroEngineered Heart Tissue for Regeneration of Injured Myocardium | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,361,276 | April 1, 2024 | January 31, 2028 | ZHU, WUQIANG | reporter.nih.gov |
| Biomarkers and pathogenesis of Alcoholic acute pancreatitis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $1,184,343 | March 1, 2024 | November 30, 2028 | SINGH, VIJAY PREM | reporter.nih.gov |
| Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,166,286 | September 16, 2024 | August 31, 2029 | BANERJEE, IMON | reporter.nih.gov |
| Dose Linear Energy Transfer Volume Histogram and Dosimetric Seed Spot Analysis in Spot Scanning Proton Therapy | NIH | National Cancer Institute | 2024 to 2025 | $1,161,152 | August 1, 2024 | July 31, 2029 | LIU, WEI | reporter.nih.gov |
| Predicting Pain Recovery: A Multimodality Machine-learning Approach using Harmonized Electronic Health Record Data | NIH | Office of the Director, National Institutes of Health | 2025 | $1,156,554 | September 15, 2025 | September 14, 2026 | CHONG, CATHERINE DANIELA | reporter.nih.gov |
| Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma | NIH | National Cancer Institute | 2021 to 2023 | $1,123,987 | December 7, 2018 | March 31, 2024 | CHESI, MARTA | reporter.nih.gov |
| Overcoming Drug Resistance in Multiple Myeloma | NIH | National Cancer Institute | 2021 | $1,065,414 | September 1, 2017 | August 31, 2023 | BERGSAGEL, PETER LEIF | reporter.nih.gov |
| Molecular functions of Tcf-1 in DP thymocytes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,042,166 | November 22, 2019 | October 31, 2025 | GOUNARI, FOTINI | reporter.nih.gov |
| A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,029,489 | May 18, 2023 | January 17, 2025 | PASRICHA, PANKAJ J | reporter.nih.gov |
| HRD-IA signatures in pancreatic ductal adenocarcinoma | NIH | National Cancer Institute | 2022 to 2024 | $966,110 | February 1, 2022 | January 31, 2025 | BORAD, MITESH | reporter.nih.gov |
| Pathogenesis of infection in pancreatitis: from sterile inflammation to sepsis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $924,056 | April 1, 2019 | December 31, 2022 | SINGH, VIJAY PREM | reporter.nih.gov |
| Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma | NIH | National Cancer Institute | 2021 | $907,551 | September 12, 2017 | August 31, 2023 | SWANSON, KRISTIN R | reporter.nih.gov |
| Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $867,228 | June 3, 2024 | May 31, 2028 | BHAT, KRISHNA PL | reporter.nih.gov |
| Engineering cell-based therapy for enhanced survival and durable function in vivo | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $832,500 | August 1, 2024 | May 31, 2029 | BOSE, SUMAN | reporter.nih.gov |
| Myocardial Repair with a Novel Engineered Cardiac Muscle Patch | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $825,686 | September 1, 2019 | August 31, 2025 | ZHU, WUQIANG | reporter.nih.gov |
| Pulmonary Rehabilitation for Rural Patients with COPD | NIH | National Institute of Nursing Research | 2025 | $784,990 | September 20, 2024 | June 30, 2030 | BENZO, ROBERTO PABLO | reporter.nih.gov |
| Mechanisms of adverse gastrointestinal events during oral immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $759,456 | July 21, 2022 | June 30, 2027 | WRIGHT, BENJAMIN L. | reporter.nih.gov |
| Molecular basis of activation of the prototypic class B G protein-coupled secretin receptor | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $744,596 | September 1, 2019 | August 31, 2024 | MILLER, LAURENCE J | reporter.nih.gov |
| Gender and Asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $737,299 | December 1, 2023 | November 30, 2027 | ZEIN, JOE | reporter.nih.gov |
| Preclinical studies for the immunoprevention of multiple myeloma | NIH | National Cancer Institute | 2025 | $704,622 | August 15, 2025 | May 31, 2027 | BERGSAGEL, PETER LEIF | reporter.nih.gov |
| An Image-Guided Microrobotic Drug Delivery Method for Preventive Vascular Interventions | NIH | National Heart, Lung, and Blood Institute | 2025 | $703,523 | May 21, 2025 | March 31, 2030 | CEYLAN, HAKAN | reporter.nih.gov |
| Programmed Cell Death 4 in Doxorubicin-Induced Cardiotoxicity | NIH | National Heart, Lung, and Blood Institute | 2025 | $695,997 | August 18, 2025 | May 31, 2029 | ZHU, WUQIANG | reporter.nih.gov |
| Online Adaptive Proton Therapy | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $695,814 | April 9, 2025 | December 31, 2028 | LIU, WEI | reporter.nih.gov |
| Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma | NIH | National Cancer Institute | 2025 | $678,428 | July 2, 2019 | July 31, 2030 | IYER, PRASAD G. | reporter.nih.gov |
| Advancing Science for the Diagnosis and Treatment of Gastroparesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $678,412 | April 15, 2006 | July 31, 2027 | PASRICHA, PANKAJ J | reporter.nih.gov |
| Treatment of arterial aneurysms using an injectable biomaterial | NIH | National Heart, Lung, and Blood Institute | 2021 | $607,500 | April 1, 2018 | June 30, 2023 | OKLU, RAHMI | reporter.nih.gov |
| Hemorrhage control in the irreversible anticoagulated patient | NIH | National Heart, Lung, and Blood Institute | 2021 | $576,210 | June 1, 2017 | March 31, 2023 | OKLU, RAHMI | reporter.nih.gov |
| Inflammatory cascades disrupt Treg function through epigenetic mechanisms | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $505,712 | February 10, 2021 | January 31, 2027 | FAUBION, WILLIAM A | reporter.nih.gov |
| Genetic Literacy and Patient-Caregiver Communication of Prognostic Genetic Technology for Localized Prostate Cancer | NIH | National Cancer Institute | 2022 to 2024 | $504,792 | September 1, 2022 | August 31, 2025 | COBRAN, EWAN KEMAR | reporter.nih.gov |
| Type 2 Immune Responses in Endotoxemia-induced Lung Injury | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $486,109 | July 1, 2025 | June 30, 2027 | JACOBSEN, ELIZABETH A | reporter.nih.gov |
| Genetic architecture of age of onset of amyloid positivity: Integrating imaging and genetic tools to identify novel drivers of disease | NIH | National Institute on Aging | 2024 to 2025 | $485,999 | August 23, 2024 | May 31, 2029 | KORAN, MARY ELLEN IRENE | reporter.nih.gov |
| Feasibility, Acceptability, and Pilot Testing of a Behavioral Intervention for Chronic Migraine | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $480,708 | September 30, 2021 | August 31, 2026 | WOLDEAMANUEL, YOHANNES WOUBISHET | reporter.nih.gov |
| Type 2 Innate Lymphoid Cells and Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 | $473,302 | November 27, 2019 | June 30, 2023 | KITA, HIROHITO | reporter.nih.gov |
| Neurodegeneration and Neuronal Fluctuations in DLB and AD | NIH | National Institute on Aging | 2023 to 2025 | $456,570 | July 5, 2023 | May 31, 2027 | CHIU, SHANNON | reporter.nih.gov |
| Tools for reversible short-term degradation of TCF-1 to address its molecular functions | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $456,500 | March 1, 2023 | December 31, 2025 | GOUNARI, FOTINI | reporter.nih.gov |
| Pulmonary Response to Ozone-exposed Ragweed Pollen Grains | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $450,000 | June 13, 2024 | April 30, 2027 | JACOBSEN, ELIZABETH A | reporter.nih.gov |
| Delineating mechanisms underlying the enhanced stability and functionality of CD2- KO Tregs and chimeric antigen receptor (CAR) Tregs and their application in xenotransplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $443,957 | January 17, 2023 | December 31, 2024 | KHOSRAVI MAHARLOOEI, MOHSEN | reporter.nih.gov |
| Longitudinal Quality of Life and What Matters Most to Older Adults with Indolent Non-Hodgkin Lymphoma | NIH | National Institute on Aging | 2025 | $420,000 | September 15, 2025 | August 31, 2027 | TSANG, MAZIE | reporter.nih.gov |
| Optimization of antigen preparations from Coccidioides for diagnostic testing | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $414,816 | December 1, 2020 | November 30, 2023 | GRYS, THOMAS E | reporter.nih.gov |
| Development of Mantle Cell Lymphoma Proliferation Signature Assay | NIH | National Cancer Institute | 2021 | $344,075 | August 1, 2017 | July 31, 2023 | RIMSZA, LISA | reporter.nih.gov |
| Increasing Adherence to Pulmonary Rehabilitation after COPD-related Hospitalizations (Transfer) | NIH | National Heart, Lung, and Blood Institute | 2022 | $342,708 | September 20, 2018 | August 31, 2025 | BENZO, ROBERTO PABLO | reporter.nih.gov |
| Roles of Group 2 Innate Lymphoid Cells in Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $298,291 | May 3, 2024 | March 31, 2025 | KITA, HIROHITO | reporter.nih.gov |
| New approaches to the pathophysiology, diagnosis and management of heparin-induced thrombocytopenia | NIH | National Heart, Lung, and Blood Institute | 2025 | $249,258 | May 25, 2026 | July 31, 2027 | PADMANABHAN, ANAND | reporter.nih.gov |
| DEFINING THE FUNCTION OF EXTRACELLULAR ATP SENSING FOR MEMORY CD8+ T CELL GENERATION AND LONGEVITY | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $249,000 | August 17, 2020 | July 31, 2022 | BORGES DA SILVA, HENRIQUE | reporter.nih.gov |
| Breaching the Tumor-Immune Mechanical Barrier for Optimal Antitumor Immunity | NIH | National Cancer Institute | 2025 | $249,000 | January 17, 2024 | July 31, 2028 | WU, BOGANG | reporter.nih.gov |
| Aging lymphocytes: senescence programs in lymphocytes relevant to human inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $163,614 | January 4, 2023 | November 30, 2027 | GONZALEZ SALGADO, MICHELLE M | reporter.nih.gov |
| A role of chromatin remodeling complexes in beta cell dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $144,126 | September 12, 2019 | August 31, 2022 | WEI, ZONG | reporter.nih.gov |
| International Conference on Advances in Quantitative Laryngology,Voice and Speech Research (AQL) | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $88,500 | February 10, 2021 | January 31, 2026 | LOTT, DAVID G | reporter.nih.gov |
| Characterizing Sleep Health, Sleep Disorders, and Cognitive Functioning After Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2025 | $80,046 | July 2, 2025 | July 1, 2027 | AL-SALEH, STACY ANNE | reporter.nih.gov |
| Society of Ears, Nose, and Throat Advances in Children (SENTAC) | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2024 | $80,000 | March 6, 2023 | February 28, 2025 | ZACHARIAS, STEPHANIE RC | reporter.nih.gov |
| Elucidating the functional role of KLRG1+ conventional helper T cells in the tumor microenvironment | NIH | National Cancer Institute | 2025 | $78,040 | August 1, 2025 | July 31, 2028 | JUGLER, COLLIN | reporter.nih.gov |
| Assessing food-specific tolerogenic CD4+ T cells in protection from food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $49,538 | May 1, 2025 | April 30, 2027 | MASUDA, MIA Y. | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 53 | $27,583,900 | 0 | $0 |
| 2024 | 49 | $26,373,061 | 0 | $0 |
| 2023 | 38 | $21,843,507 | 0 | $0 |
| 2022 | 32 | $18,379,636 | 0 | $0 |
| 2021 | 23 | $14,732,262 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 7 awards here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 16 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 16 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
Topics of its NIH awards
- Clinical Research
- Biotechnology
- Cancer
- Genetics
- Translational Research
- Prevention
- Bioengineering
- Digestive Diseases
- Rare Diseases
- Neurosciences
- Immunotherapy
- Biomedical Imaging
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.